RNAC - Cartesian Therapeutics, Inc.
IEX Last Trade
19.22
-0.540 -2.810%
Share volume: 200
Last Updated: Fri 27 Dec 2024 05:26:10 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$19.76
-0.54
-2.73%
Summary score
35%
Profitability
50%
Dept financing
25%
Liquidity
60%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
46.39%
Return on assets
-5.08%
Return on sales
-129.47%
Return on invested capital
41.87%
Total debt ratio
86.42%
Debt ratio change over timeo
-1.58%
Current Ratio
3.34%
Quick Ratio
3.34%
Cash Position Ratio
3.01%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
35.89%
Return on assets
-10.42%
Return on sales
-305.65%
Return on invested capital
43.85%
Total debt ratio
94.47%
Debt ratio change over timeo
-2.12%
Current Ratio
3.26%
Quick Ratio
3.26%
Cash Position Ratio
2.94%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
48.65%
Return on assets
-4.1%
Return on sales
-228.56%
Return on invested capital
-32.02%
Total debt ratio
135.92%
Debt ratio change over time
-2.12%
Current Ratio
3.03%
Quick Ratio
3.03%
Cash Position Ratio
2.82%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-199.33%
Return on assets
-108.41%
Return on sales
-88.89%
Return on invested capital
59.58%
Total debt ratio
-157.75%
Debt ratio change over time
-1.58%
Current Ratio
-0.87%
Quick Ratio
-0.87%
Cash Position Ratio
-0.84%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNAC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 46.39% | 13.79% | 34.47% | 7.43% |
| Return on assets | -5.08% | 2.76% | 3.15% | 5.62% |
| Return on sales | -129.47% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 41.87% | 2.36% | 5.39% | 19.77% |
| Profitability | 50% | 39% | 56% | 66% |
| Total debt ratio | 86.42% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.58% | 308.97% | -6.99% | 1.18% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 3.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.94% | 0.36% | 1.28% | 2.93% |
| Liquididy | 66% | 13% | 29% | 67% |
| Short-term ratios | RNAC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 35.89% | 13.77% | 13.25% | 3.8% |
| Return on assets | -10.42% | 2.43% | 1.89% | 3.09% |
| Return on sales | -305.65% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 43.85% | 2.14% | 3.39% | 9.18% |
| Profitability | 50% | 51% | 46% | 58% |
| Total debt ratio | 94.47% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.12% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 49% | 25% | 7% |
| Current Ratio | 3.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.94% | 0.36% | 1.28% | 2.93% |
| Liquididy | 58% | 12% | 31% | 75% |